Tricks and Tips

Wednesday, 21 October 2015

Human Insulin Share, Key Trends, Vendor Strategies, Application Analysis, Regional Outlook & Forecasts to 2015

Insulin is a hormone produced by beta cells of the pancreas that plays a key role in the regulation of blood glucose levels. It controls the body systems and regulates the uptake of amino acids by body cells. It helps cells absorb glucose from the blood. In diabetics, cells stop responding to the insulin produced. As a result, glucose in the blood cannot be absorbed by the cells of the body. This condition damages body tissues over the period of time and causes disabling and life-threatening health complications such as diabetic nephropathy and diabetic retinopathy. In type 1 diabetes, the body does not produces sufficient insulin to regulate blood glucose level. Individuals with this type of diabetes need to take insulin daily. Patients with type 2 diabetes also need doses of insulin coupled with medication. Different types of insulin such as human insulin and insulin analogs are available as insulin replacement therapy.

Technavio's analysts forecast the global human insulin market to grow at a CAGR of 10.29% over the period 2014-2019.                    

Covered in this report
The report includes the present scenario and the growth prospects of the global human insulin market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various drugs used in the treatment of diabetes.

Technavio's report, Global Human Insulin Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report includes a discussion of the key vendors operating in this market.

Key vendors
  •  Eli Lilly
  •  Novo Nordisk
  •  Sanofi
Other prominent vendors 
  • Biocon
  •  Biodel
  •  Biogenomics
  •  Boehringer Ingelheim 
  •  Bristol-Myers Squibb
  •  Diamyd Medical 
  •  Diasome Pharmaceuticals
  •  DiaVacs 
  •  Pfizer 
  •  Generex Biotechnology 
  •  Lexicon Pharmaceuticals
  •  Macrogenics 
  •  Merck
  •  Oramed Pharmaceuticals
  •  Osiris Therapeutics
  •  Thermalin Diabetes
  •  Tolerion 
  •  Wockhardt
  •  XOMA Corporation
Market driver
 Increase in prevalence of diabetes
 For a full, detailed list, view our report

Market challenge
  •  Stringent regulatory environment
  •  For a full, detailed list, view our report
Market trend
  •  Increasing R&D for novel mechanisms
  •  For a full, detailed list, view our report
Key questions answered in this report
  •  What will the market size be in 2019 and what will the growth rate be?
  •  What are the key market trends?
  •  What is driving this market?
  •  What are the challenges to market growth?
  •  Who are the key vendors in this market space?
  •  What are the market opportunities and threats faced by the key vendors?
  •  What are the strengths and weaknesses of the key vendors?
Table Of Content 

PART 01: Executive summary
PART 02: Scope of  the report
 Market overview
 Top-vendor offerings
PART 03: Product profiles
PART 04: Market research methodology
 Research methodology
 Economic indicators
PART 05: Disease overview
PART 06: Pipeline analysis

Request A Sample copy of This Report @

PART 07: Introduction
 Key market highlights
PART 08: Market landscape
 Market overview
 Market size and forecast
 Five forces analysis
PART 09: Market segmentation by type of insulin
 Fast-acting insulin
 Intermediate-acting insulin
 Long-acting insulin
PART 10: Market segmentation by type of disease
PART 11: Geographical segmentation
PART 12: Market drivers
PART 13: Impact of drivers
PART 14: Market challenges
PART 15: Impact of drivers and challenges

Browse Full Report @

About Us:

Hexa Reports is a market research and consulting organization, offering industry reports, custom research and consulting services to a host of key industries across the globe. We offer comprehensive business intelligence in the form of industry reports which help our clients obtain clarity about their business environment and enable them to undertake strategic growth initiatives.

Contact Information:

Ryan Shaw

Felton Office Plaza,
6265 Highway 9,
Felton, California, 95018,
United States
Phone Number
Email Us:
Our Website: 

No comments:

Post a Comment